Does anyone know how long fermi are planning to offer the test free in conjuction with other investigations (mammo etc) at the Syd breast clinic? Whilst I can see the benefits of increasing the number of cases for better statistics, I was anticipating commercialisation at end of 2008?? Not long left if that is still the plan. Pleasing to see that international trials are progressing eg Italy, Asia etc. The potential market for this is truly phenomenal.
This share is a great example why the ASF is such a great asset to us all.
I have never heard about this company, but after it was bumped here, I read the entire thread, did some research, and thinking of investing @ near a major low.
Thankyou for the heads up!
PS: I hope you haven't been too hurt by this one, really unfairly penalized it seems, cheers...
No problem! When you buy, make sure you take out the sell column hey! That will get the price up to $1.20 quite quickly!
Fermiscan today announced that it has concluded a commercial user agreement with the Australian Synchrotron in Melbourne. The agreement covers two years and provides for scheduled weekly access at the synchrotron which is Australia’s newest and most advanced major research facility.
Fermiscan’s principal activity is the commercialisation of an innovative non-invasive diagnostic test for the detection of breast cancer.
The Australian Synchrotron is a world-class facility with a rapidly growing reputation for producing high-quality results. By the end of 2009, it will be the largest scientific user facility in the southern hemisphere. The synchrotron produces a highly intense source of light ranging from infrared to monochromatic x-rays. The unique properties of synchrotron light mean that results are far superior in accuracy, clarity, specificity and timeliness to those obtained using conventional x-ray equipment.
Anthill magazine said the Fermiscan test was “A breathtaking innovation with the potential to save thousands of lives. The Fermiscan Breast Cancer Test wowed our mavens and is a worthy winner of Anthill’s inaugural Smart 100 awards.” The Awards process took more than six months and winners were announced at a ceremony on Thursday 9 April 2009 at Melbourne Docklands.
Fermiscan’s Managing Director, David Young, said ”We are particularly pleased to receive this award as it recognises not only ingenuity and innovation, but also our potential for rapid commercial growth. The Fermiscan Breast Cancer Test was ranked first among an extremely impressive field of innovations from many industries, and judged by experts recognised for their ability to select winners in business. We would like to thank Australian Anthill and everyone who participated in the awards.”
The Fermiscan Test is based on the discovery that the presence of breast cancer can be detected through the analysis of a patient’s hair using sophisticated technology based on X-ray diffraction using synchrotron-generated light. Fermiscan recently entered into a commercial agreement with the Australian Synchrotron in Melbourne and expects to begin commercialisation of its test in Australia in the near future.
Certainly no takeover attempt until over 50% of the shares come out of escrow in October 2008. See my previous posts re: tightly held by top 20. Personally, hope we don't get taken out as I'm here for the long-run, and once we pass 2000 tests, there will be no stopping this one.
Would certainly appeciate others' opinions though!
Grace, I have bought FER two weeks ago as I respect your opinions (I know you from PES and AOE threads). I made a research myself and have seen a lot of potantial for FER. (It could be another PES)
What do you think about this takeover bid by PLT?
I am not convinced as PLT has 31M market value while FER has 75M !
What happens if we don't sell and wait?
Do you think if there could be another bid from another company?
Regards.
The discoverer of a breast cancer test being developed by listed biotech Fermiscan and which is set to save millions of women's lives was too choked up to speak to BNW.
The recipient of an Order of Australia award for her extraordinary work with hundreds of deaf children was too scared to talk.
The respected scientist whose work has not been able to be replicated anywhere in the world with the same success was struggling to control the quiver in her voice.
So, this is what they have done to Professor James - they have gagged her. The tactics Fermiscan has used against a distinguished scientist are a disgrace.
The rest of the biotech sector should condemn the way this talented researcher, who gave away her life's work in the hope of saving others lives, has been treated.
Every self-respecting person working in the life sciences sector who values peer review of scientific discoveries has a responsibility to make sure the case concluded by Justice McDougall is the final chapter in this saga.
Each time BNW has called Fermiscan, chief executive David Young has been too busy to talk. A call to Fermiscan's founder and current corporate strategist, Leon Carr, also was not returned.
You remember Leon? The investment banker linked with the now defunct Medicine Quantale.
Well, now Leon has another company called Rellcain and it recently agreed to sell a 19.9 per cent stake in Fermiscan to Polartechnics.
Polartechnics chief executive Ben Dillon, who surprisingly was willing to talk to BNW, said the adverse finding against Fermiscan did not automatically rule out the merger, but he would wait to read the full judgment before making a call.
Yep, BNW is also looking forward to reading the detailed judgment, which should be available from the court transcribers this week.
hmmm...Pity Fermiscan didn't tell their shareholders this...I'm surprised they had money at all...IMHO...If you thieve someone else's hard earned work and get caught, you pay the price.....Sucked in...Tried to do pull a Einfield, eh leon and david
Let me to them first...
i wonder what tactics they will use now
Grace, I wouldn't jump up and down without knowing what your talking about...How much do you really know about this company...shows already...not too much
news.com.au/heraldsun/story/0,21985,25583768-664,00.html
Thrown out of court last week were Fermiscans claims that Prof James' later inventions involving skin and nail tests were owned by them as "improvements" on her original hair diagnostic test.
Grace and others...
what do you think about the ''TAKE NO ACTION'' on the merge?
i for all would be happy to stay independent
we have to be so close now to start selling the test... sydney breast clinic has using the test almost for a year now..?
althou no updates on that....
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?